Clover Health Investments Corporation (CLOV) Quote

CLOV new 52 lo

CLOV new 52 lo

How’s that working for you now hope you covered
Lmfao

This one is still heavily naked shorted IMO. It's just silly me though.

Going to pop soon

Like it!!!!

Boing??

Thanks GC

This is the figure I have 26.11M from finviz... 7.04% of the float short... GLTA

Any idea if $CLOV is still heavily shorted~? "They hide everything so well.
mark short shares as long shares and other nefarious stuff.

Anyone have any idea~? Still hold some CLOV.

TIA

This does not want to move

CLOV had a golden cross of the 50/200dma today... Chart in strong reversal mode...

Posting old articles. How much money are you losing? No comment on the great earnings?

https://www.fiercehealthcare.com/payers/clover-health-avoids-potential-nasdaq-stock-delisting

"We’re delighted to have delivered our first quarterly Adjusted EBITDA profit as a public company,” said Clover Health CEO Andrew
Toy.

Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance
Ranges
Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2%, bringing first half MCR to
81.9%
Company reports Q2 Net Loss of $28.8 million, and Adjusted EBITDA profit of $10.0 million
Improved 2023 guidance includes Insurance MCR of 83% - 85%, and Adjusted EBITDA of ($70) million - ($120) million
FRANKLIN, Tenn. - August 8, 2023 – Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the
"Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today
reported financial results for the second quarter 2023. Management will host a conference call today at 5:00 p.m. ET to discuss its
operating results and other business highlights.
For the second quarter 2023, the Company reported revenue of $513.6 million and net loss of $28.8 million. Adjusted EBITDA in the
second quarter 2023 improved to a gain of $10.0 million compared to the second quarter 2022 loss of $83.9 million. Compared to the
second quarter 2022, Insurance revenue grew by 17% to $314.4 million, and MCR improved to 77.2% from 92.1%. As contemplated
in the Company's previously disclosed strategic shift for the Non-Insurance segment, Non-Insurance revenue declined by 67% to $193.5
million, and MCR improved to 99.6% from 106.0%.
"We’re delighted to have delivered our first quarterly Adjusted EBITDA profit as a public company,” said Clover Health CEO Andrew
Toy. “We have been strategically focused on demonstrating the strength of our model by maturing operations, driving efficiencies, and
continuing to invest in Clover Assistant R&D and our home care capabilities. We have multiple exciting initiatives in each of these
areas that we expect will allow us to maintain our momentum through the second half of the year and into 2024. We are reflecting that
expectation via significantly improved full year 2023 guidance for the Insurance segment and on a consolidated basis."
"Insurance MCR improved by more than 1,400 basis points and Non-Insurance MCR improved by more than 600 basis points,
demonstrating the strength of our strategy and our ability to make strides towards sustainable profitability,” said Clover Health CFO
Scott Leffler. “We are excited about our improved outlook for 2023, the favorable impact on our liquidity position, and are also
increasingly confident in the Company’s potential to deliver profitability on an Adjusted EBITDA basis for full year 2024 without the
necessity of raising additional capital."
https://investors.cloverhealth.com/static-files/3731b516-6961-45d8-aba6-7509a4b31791

Do what’s best for you. I wish you the best the history of this company speaks for itself.

Brining up old news like you know what your talking about. Hope you covered.

The truth will set you free. I wish you the best

If you don't want to read the filings that is fine. Very typical in wall st. I'll be fine with my average of $1.03

Crooks

Clover Health: How the “King of SPACs” Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation

https://hindenburgresearch.com/

Spin it how you want cfo dumped 350 thousand just the other day
Sorry your screwed

So many incorrect shit posting.
1) It was for tax obligations like an other stock RSU's
2) NASDAQ compliant today (10 days over $1)
3) there is no R/S, but there is a vote for one (NASDAQ compliant might make that useless now)
4) settled lawsuit = great
5) share dilution at $5.75 was the right call considering this dropped below a $1 and would have had to dilute more if they waited

1. Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 25, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 25, 2022, and timely reported on a Form 4 filed on July 25, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after July 25, 2023, in each case subject to the continued service of the Reporting Person on such vesting date.

https://www.sec.gov/Archives/edgar/data/1801170/000089534523000420/xslF345X05/form4.xml

CFO sold shares. it’s posted in filings not a good sign

Summary of events

Company settled lawsuit paying out millions to investors for sec rulings they lost

Then they do a big share selling on market diluting stock

Now there doing a reverse split the other way.

Obviously pissed they had to payout

It’s their leadership failure stealing more shareholders money but I’m sure they would say it’s just business

Rev split 1 for 5 or 1 for 20. Bunch of crooks

points are all wrong , its already succeeding in its software CLOV

Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It?

https://www.fool.com/investing/2023/07/09/clover-health-is-down-68-in-1-year-but-wall-street/

Surprised this hasn't popped yet. Financials looked better than I expected.

sold out long ago

Ouch! sorry bro. That's a huge loss.

cool, ya try and buy the dip https://stockcharts.com/h-sc/ui?s=CLOV

That was a massive position, im just a tiny investor. nowhere your sacale. but will add a bit here

HR

:) had 60k sold out made 4k sold early on Friday and bought 15k shares of SH @ 15.48 betting on the S&P dropping , CLOV will do well late into 2023 and 2024 , I will buyback for sure CLOV

Have not sold a single share in this stock since I bought, and have not bought any for about a year. considering now is the time to add again, and down average cost.

Markets look good

Wes Christian might be our saviour.

HR

buck 60 coming CLOVER

going 50 cents

$CLOV is a buy right now. Time to load up. JMO

my brother has 40k CLOV

more good news CLOV got 26k shares buying more

good news folks CLOV

buying more CLOV

hey folks trouble times ahead , buck 1.40 is a buy CLOV

ask Trump was right about 90% of the time , receipts r in CLOV will be fine , long term 2026 so long as they stop with dilution could see easy 40 CLOV

Seems so true, manipulators every stock doing their dirty criminal work

HA

Chelsea Handler~?
$CLOV is a MEME stock that has been chopped to death.
Take a look at Accolade ($ACCD) if you think $CLOV is bad.

I still think a huge naked short position in $CLOV.
Manipulation continues.......

Main MM controls most everything..... ask Kenny Griffin and Citadel.
Chelsea's got nothing to do with this, accept maybe she is waiting for squeeze too. If she sells, then things may really be Eff'd up.

I dunno ask Spuds... LMMFAO~!

Does anyone know how long Chelsea has to hold Clover
stock before she can sell? Is there any good news in sight? I can't find any.

This MEME $CLOV will run when the time is right.

Massive call volume at 2.50 strike for Friday

“6:40p ET 6/24/2022 - Globe Newswire
Clover Health Set to Join Russell 3000(R) Index

EQNX::TICKER_START (NASDAQ:CLOV), EQNX::TICKER_END Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to improving health equity for seniors, is set to be added as a member of the broad-market Russell 3000(R) Index, effective after the US market opens on June 27, 2022 as part of the 2022 Russell indexes reconstitution, according to a preliminary list of additions posted on June 3, 2022.

Annual reconstitution of the Russell indexes captures the 4,000 largest US stocks as of May 6, 2022, ranking them by total market capitalization. Membership in the Russell 3000(R) Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000(R) Index or small-cap Russell 2000(R) Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.

"This is another significant milestone for Clover Health as a public company on our mission to improve every life," said Vivek Garipalli, CEO of Clover. "We welcome the enhanced exposure and visibility provided by our inclusion in the index as a way to broaden awareness and engagement within the investment community as we execute upon our strategy."

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $12 trillion in assets are benchmarked against Russell's US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.

For more information on the Russell 3000(R) Index and the Russell indexes reconstitution, go to the "Russell Reconstitution" section on the FTSE Russell website.
”

Highest volume day since November 18, 2021